control group:Tongxinshu capsule analog agent

2 trials

Sponsors

Guang'anmen Hospital, China Academy of Chinese Medical Sciences

Conditions

Coronary heart disease stable angina pectoris

Phase 4

Effectiveness and Safety of Tongxinshu Capsule in Treating Stable Angina Pectoris of Coronary Heart Disease with Qi Deficiency and Blood Stasis Syndrome

RecruitingChiCTR2000039731

Guang'anmen Hospital, China Academy of Chinese Medical SciencesCoronary heart disease stable angina pectoris

Start: 2020-10-31Updated: 2021-02-16

Effectiveness and Safety of Tongxinshu Capsule in Treating Stable Angina Pectoris of Coronary Heart Disease with Qi Deficiency and Blood Stasis Syndrome

RecruitingITMCTR2100004438

Guang'anmen Hospital, China Academy of Chinese Medical SciencesCoronary heart disease stable angina pectoris

Start: 2020-10-31Updated: 2023-02-20

Related Papers

Tongxinshu capsules in the treatment of stable angina pectoris due to qi deficiency and blood stasis in coronary heart disease: A multicenter, randomized, double-blind, placebo-controlled trial

Journal of Ethnopharmacology2025-02-044 citations